News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Testing Procedures and Considerations

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

BySpencer Feldman

November 13th 2025

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

FDA sign image

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

November 13th 2025

Image of FDA.

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

November 13th 2025

Trending on CURE

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

Detalimogene Shows 62% Response Rate in Bladder Cancer Trial

© 2025 MJH Life Sciences^®

All rights reserved.